Answers are grounded in this paper and cite their sources.
India's substantial dengue disease burden, with an estimated 12.9 million primary infections annually, presents a significant public health challenge.1 This extensive disease prevalence, coupled with the complex immunological dynamics of dengue virus serotypes, poses considerable obstacles to the development and implementation of effective dengue vaccines in India. 2 Therefore, as the country prepares for phase 3 trials of quadrivalent dengue vaccines, understanding regionspecific circulating dengue virus serotypes is crucial.3 Southern India reports the highest dengue seroprevalence, estimated at 77%. 1 At present, Karnataka, a southern Indian state, is witnessing a surge in dengue cases, with 9880 cases reported from January to July, 2024 by the Government of Karnataka, compared to 2271 cases in the same period last year.Bangalore, the state capital, has been particularly affected by this spike with 8160 cases reported in these 7 months.4 To assess the current serotype distribution, we analyzed 1600 samples from acute febrile illness patients across all eight zones of urban Bangalore (East, South, West, Bommanahalli, Dasarahalli, Mahadevapura, Rajarajeshwari Nagar and Yelahanka).Samples were collected through health centers under the municipal corporation, Bruhat Bengaluru Mahanagara Palike (BBMP), between April and July 2024 and tested at the Department of Neurovirology, National Institute of Mental Health and Neurosciences (NIMHANS).Of these, 549 (34.3%) tested positive for dengue NS1 antigen and/or anti-dengue IgM by ELISA.Real-time PCR analyses of 507 (92.3%) dengue NS1 positive samples revealed 228 (45%) were positive for DENV serotypes, showing a striking predominance of DENV-3 (182, 79.8%), followed by DENV-1 (27, 11.8%), DENV-2 (19, 8.3%), and DENV-4 (3, 1.3%).Additionally, 3 (1.3%)samples showed DENV-2 and DENV-3 coinfection (Fig. 1).Our findings may indicate a potential shift in serotype dominance towards DENV-3 from DENV-4, which has been the predominant serotype in Southern India
No takes yet. Share an insight, caveat, or question.
Uppoor et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: